Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal AdenocarcinomaChangqing Xie, Austin G Duffy, Gagandeep Brar, et al.The Journal of Clinical Investigation|July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumorsDanny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2025
Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous MelanomaPaul H McClelland, Shirley K Nah, Alexandra M Gustafson, et al.Science (New York, N.Y.)|March 14, 2015
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancerNaiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, et al.Journal for Immunotherapy of Cancer|May 30, 2024
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypesNoam Levin, Sanghyun P Kim, Charles A Marquardt, et al.Proceedings of the National Academy of Sciences of the United States of America|August 3, 2026
Cell surface ADGRG1 and CD86 expression identifies antitumor CD4+ T cells in human cancerKyle J Hitscherich, Aaron J Dinerman, Abraham A Hakim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic MelanomaShoshana T Levi, Amy R Copeland, Shirley Nah, et al.Biorxiv : the Preprint Server for Biology|June 4, 2025
Rapid enrichment of progenitor exhausted neoantigen-specific CD8 T cells from peripheral bloodMamduh Khateb, Raina Jung, Stav Leibou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2022
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous LymphocytesNikolaos Zacharakis, Lutfi M Huq, Samantha J Seitter, et al.Cell|March 31, 2023
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variantsDaniel Hirschhorn, Sadna Budhu, Lukas Kraehenbuehl, et al.Pageof 4